Clinical trial NCT00986219: A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms
Official title: A Cross Sectional Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms and the Limitations of Daily Activities in Primary Care. The " Asthma Language " Survey
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Asthma
Keywords: Asthma
Language
Symptoms,
Limitation of Daily activities
Patients
Physicians
Greece
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2009-09-29
Enrollment: 696
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: Primary care patients with persistent asthma treated with inhaled corticosteroid-based maintenance treatment for at least 6 months and followed up by thep hysician for at least the same period of time.

Brief summary: The purpose of the study is to evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma.


Eligibility criteria: Inclusion Criteria:

* Diagnosis of persistent asthma treated with inhaled corticosteroid-based maintenance treatment for at least 6 months and followed up by the investigator for at least the same period of time

Exclusion Criteria:

* Patient with a cardiac disease (congestive heart failure, coronary heart disease)
* Patient with a respiratory disease other than asthma (COPD, sleep apnoea syndrome)

Primary outcomes:
measure: The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma
timeFrame: Day 1
Secondary outcomes:
measure: The most frequently used words (lexical intensity) by the patient and the physician to express asthma symptoms and the limitations of daily activities.
timeFrame: Day 1
measure: The concordance of words used by physicians and patients according to the level of asthma control (as assessed by ACQ).
timeFrame: Day 1
measure: The actions recommended by the physician or those initiated by the patient and are associated with words that express symptoms.
timeFrame: Day 1
Other outcomes:
Locations:
city: Patras
country: Greece
facility: Research Site
state: Achaia
city: Agrinio
country: Greece
facility: Research Site
state: Aitoloakarnanias
city: Thermo
country: Greece
facility: Research Site
state: Aitoloakarnanias
city: Naupaktos
country: Greece
facility: Research Site
state: Aitoloakarnania
city: Argos
country: Greece
facility: Research Site
state: Argolida
city: Arta
country: Greece
facility: Research Site
state: Artas
city: Athens
country: Greece
facility: Research Site
state: Attiki
city: Peraious
country: Greece
facility: Research Site
state: Attiki
city: Livadia
country: Greece
facility: Research Site
state: Biotias
city: Chania
country: Greece
facility: Research Site
state: Crete
city: Herakleion
country: Greece
facility: Research Site
state: Crete
city: Rethimno
country: Greece
facility: Research Site
state: Crete
city: Siros
country: Greece
facility: Research Site
state: Cyclades
city: Rodos
country: Greece
facility: Research Site
state: Dodekanisou
city: Drama
country: Greece
facility: Research Site
state: Drammas
city: Kastoria
country: Greece
facility: Research Site
state: Florinas
city: Amfisa
country: Greece
facility: Research Site
state: Fokidos
city: Pirgos
country: Greece
facility: Research Site
state: Ilia
city: Veroia
country: Greece
facility: Research Site
state: Imathia
city: Ioannina
country: Greece
facility: Research Site
state: Ioanninon
city: Karditsa
country: Greece
facility: Research Site
state: Karditsis
city: Chrisoupoli
country: Greece
facility: Research Site
state: Kavalas
city: Kavala
country: Greece
facility: Research Site
state: Kavalas
city: Loutraki
country: Greece
facility: Research Site
state: Korinthia
city: Ptolemaida
country: Greece
facility: Research Site
state: Kozani
city: Ksanthi
country: Greece
facility: Research Site
state: Ksanthis
city: Larisa
country: Greece
facility: Research Site
state: Larisas
city: Farsala
country: Greece
facility: Research Site
state: Larrisa
city: Volos
country: Greece
facility: Research Site
state: Magnisia
city: Kalamata
country: Greece
facility: Research Site
state: Messinia
city: Aikaterini
country: Greece
facility: Research Site
state: Peierias
city: Edessa
country: Greece
facility: Research Site
state: Pella
city: Komotini
country: Greece
facility: Research Site
state: Rodopi
city: Serres
country: Greece
facility: Research Site
state: Serron
city: Igoumenitsa
country: Greece
facility: Research Site
state: Thesprotia
city: Salonika
country: Greece
facility: Research Site
state: Thessalonikis
city: Trikala
country: Greece
facility: Research Site
state: Trikalon
city: Chalkida
country: Greece
facility: Research Site
city: Chalkidiki
country: Greece
facility: Research Site
city: Lakonia
country: Greece
facility: Research Site
Study officials:
affiliation: Director of the 7th Respiratory Clinic, Sotiria Hospital, Athens, Greece
name: Mina Gaga, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: Marketing Company Medical Director, AstraZeneca Greece
name: Panagiotis Pontikis, Dr.
role: STUDY_DIRECTOR
References: